Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Early-stage Parkinson's Disease
NCT03727295Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of idebenone in Parkinson's disease (PD) (3 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Evaluation of the efficacy on motor symptoms and non-motor symptoms at 48 weeks. Status: unknown.
02
Drugs
idebenone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03727295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03727295.